Home > Boards > US OTC > Biotechs >

ProMIS Neurosciences Inc. (ARFXF)

ARFXF RSS Feed
Add ARFXF Price Alert      Hide Sticky   Hide Intro
Moderator: Phoenix300
Search This Board: 
Last Post: 3/3/2020 6:52:29 AM - Followers: 30 - Board type: Free - Posts Today: 0

ProMIS Neurosciences
ProMIS Neurosciences Inc.
1920 Yonge Street
Suite 200
Toronto, ON M4S 3E2
Canada
416-847-6898
http://www.promisneurosciences.com

ProMIS Neurosciences Inc., a development stage biotech company, discovers and develops therapeutics and diagnostics for the treatment of neurodegenerative diseases in Canada. It develops technology for treatment of Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's disease (AD). The company has strategic alliances with Epitomics Inc. to develop murine monoclonal antibodies; and license agreement with Biogen Idec for developing therapeutics to treat ALS. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences Inc. in July 2015. ProMIS Neurosciences Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
 
 
Harnessing the power of precision medicine to conquer Alzheimer's disease



Corporate Overview    ------>    January 2019
https://promisneurosciences.com/wp-content/uploads/2019/01/ProMIS_Noblecon_Jan28-sm.pdf


Video Presentations:

January 2019   Eugene Williams presents ARFXF   Promis Neuroscience

http://noble.mediasite.com/mediasite/Play/7b08d05285e14f2ba33da64cd19ecda11d?catalog=88b4f8c61c9e48d6a6aab5f4bfb5550f21



Eugene Williams, Executive Chairman presents at Noble Capital Markets' Fourteenth Annual Investors Conference
https://promisneurosciences.com/presentations/eugene-williams-executive-chairman-presents-noble-capital-markets-fourteenth-annual-investor-conference/


Dr. Elliot Goldstein, President and CEO presents at Cantech Investment Conference January 31, 2018
https://www.youtube.com/watch?v=TglpDeE1xZ4



Poster:
Achieving the optimal profile for Alzheimer's immunotherapy: Rational generation of antibodies specific for toxic AB oligomers
https://promisneurosciences.com/2016site/wp-content/uploads/2017/04/April-17-Final-Plotkin-AAN_Poster-3-1.pdf

ARFXF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ARFXF News: Small Company Offering and Sale of Securities Without Registration (d) 11/20/2019 02:32:44 PM
ARFXF News: Small Company Offering and Sale of Securities Without Registration (d) 01/31/2019 04:45:30 PM
ARFXF News: Small Company Offering and Sale of Securities Without Registration (d) 05/03/2018 03:51:42 PM
ARFXF News: Amorfix announces fiscal 2014 year end results 06/13/2014 06:00:00 PM
ARFXF News: William Wyman appointed Amorfix Chairman of the Board 06/12/2014 07:30:00 AM
PostSubject
#402  Sticky Note “Buffett betting on aducanumab? Berkshire Hathaway takes a Phoenix300 02/14/20 07:16:15 PM
#407   Tau Shows Promise as Achilles’ Heel for Alzheimer’s noretreat 03/03/20 06:52:29 AM
#406   News. ProMIS Neurosciences initiates Natural History Study of Phoenix300 02/26/20 09:07:58 AM
#405   ProMIS Neurosciences Announces Gross Proceeds of $1,257,970 Related Phoenix300 02/25/20 09:10:13 AM
#404   Related item....Berkshire-Hathaway and Biogen. noretreat 02/21/20 09:23:19 AM
#403   positive sign for both BIIB and ARFXF noretreat 02/16/20 12:39:19 PM
#402   “Buffett betting on aducanumab? Berkshire Hathaway takes a Phoenix300 02/14/20 07:16:15 PM
#401   sticky noretreat 02/12/20 03:25:51 PM
#400   ProMIS discovery platform provides a unique competitive advantage, Phoenix300 02/11/20 04:40:12 PM
#399   Slide deck presentation https://promisneurosciences.com/wp-content/uploads/2020 Phoenix300 02/11/20 04:35:29 PM
#397   ProMIS Neurosciences to Participate in Noble Capital Markets Phoenix300 02/11/20 09:20:23 AM
#396   ProMIS Neurosciences to Participate in the BIO CEO Phoenix300 02/06/20 09:15:51 AM
#395   ProMIS Neurosciences Data for Alzheimer’s Disease Program Targeting Phoenix300 01/29/20 01:44:32 PM
#394   Sachs Neuroscience Innovation Forum Presentation By Promis Neuro Admin Phoenix300 01/28/20 09:24:05 AM
#393   Tiny volume noretreat 01/17/20 12:08:37 PM
#392   When this pops it could rocket up. Phoenix300 01/17/20 11:44:58 AM
#391   Up almost 50% on the last tranche purchased noretreat 01/16/20 07:25:46 PM
#390   Touched .18 today .19’s aren’t far away. Phoenix300 01/16/20 05:34:26 PM
#389   But price down slightly.... noretreat 01/13/20 01:03:48 PM
#388   Over 1,000,000 shares traded today 500,000 on the Phoenix300 01/13/20 12:11:19 PM
#387   ProMIS Neurosciences to present at Sachs 3rd Annual Phoenix300 01/09/20 09:29:01 AM
#386   “ProMIS is in a unique position to contribute noretreat 01/08/20 09:23:30 AM
#385   ProMIS Neurosciences issues Chairman’s Update detailing positive outlook Phoenix300 01/08/20 09:11:24 AM
#384   Elliot is presenting Sunday at CNS. I noretreat 01/07/20 04:36:47 PM
#383   ARFXF J P Morgan/Biotech Conference Phoenix300 01/06/20 11:19:34 PM
#382   rumors at this point, along with company releases noretreat 01/03/20 03:16:50 PM
#381   ARFXF Up 5% Ask .1476 25,000 Bid .14 Phoenix300 01/02/20 01:40:09 PM
#380   ProMIS Neurosciences Completes Second Closing of Private Placement noretreat 01/01/20 08:53:36 PM
#379   Added here. January puts them closer to inking Phoenix300 12/28/19 07:02:31 PM
#378   Aducanumab is good; next generation Alzheimer’s disease therapies noretreat 12/05/19 02:08:11 PM
#377   ProMIS Neurosciences Announces Third Quarter 2019 Results noretreat 11/14/19 09:22:31 AM
#376   "We are pleased to offer this private placement noretreat 11/13/19 11:58:04 AM
#375   ProMIS Neurosciences Is ProMIS’ Alzheimer’s Antibody Better Than Biogen’s? noretreat 10/28/19 01:48:04 PM
#374   Memorandum from Executive Chairman Eugene Williams: noretreat 10/25/19 12:09:17 PM
#373   The white paper.... noretreat 10/25/19 12:07:17 PM
#372   Uptrend continues. ARFXF Phoenix300 10/24/19 04:44:09 PM
#371   ProMIS Neurosciences issues Chairman's update memorandum and white noretreat 10/24/19 09:42:37 AM
#370   No question. This is an opportunity to accumulate. noretreat 10/23/19 09:22:19 PM
#369   ARFXF is undervalued now. A deal Phoenix300 10/23/19 04:42:24 PM
#368   "The momentum behind each of our programs is noretreat 10/23/19 09:17:16 AM
#367   I bet there was!! Some phones rang today. Phoenix300 10/22/19 08:47:49 PM
#366   Lots of excitement today at Promis. noretreat 10/22/19 07:38:24 PM
#365   Biogen Surges After Announcing Plans to Pursue Alzheimer's Phoenix300 10/22/19 08:31:11 AM
#364   ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple Phoenix300 10/08/19 09:04:52 AM
#363   ProMIS near-term goal is partnering in 3-12 months. noretreat 09/11/19 10:18:31 AM
#362   Yes ... should be an update on clinical noretreat 09/05/19 02:38:03 PM
#361   Someone taking a position perhaps. Conference next week Phoenix300 09/05/19 02:36:05 PM
#360   One day rally noretreat 09/05/19 02:35:15 PM
#359   Interesting................. Phoenix300 09/04/19 03:54:42 PM
#358   should be the 3rd highest volume day in noretreat 09/04/19 03:11:27 PM
#357   Up 20% intraday Phoenix300 09/04/19 10:51:15 AM
PostSubject